Rising Demand For Tissue Engineering And Organ Transplantation Will Boost The Organoids And Spheroids Market, Forecast To Touch US$ 1.8 Bn By 2027 At A CAGR Of 19.8%
iCrowd Newswire
The
organoids and spheroids market are growing at a steady pace on account of the innovation in the tissue culture system and frequent failures in organ transplantation surgeries, and the technological developments in the 3D spheroid technology. The growth of the organoids and spheroids market is further driven by the surging demand for organoid-based research models in the developed regions and the increased application of organoid culture in drug discovery. Both organoid and spheroid technology has been extensively used in personalized medicine, disease modeling, and optimizing drug discovery and regenerative medicine. Mainly, the application of organoids is gaining considerable momentum in CRISPR research that could potentially help scientists and researchers better interpret organ development from
Tue, 09 Mar 2021 00:00 UTC
US, UK, Canada, Australia, Switzerland and Singapore Will Let New-Variant Vaccines Onto the Market Without Safety or Efficacy Testing
identical guidelines for fast-tracking release onto the market of vaccines for the new variants. The countries issued the recommendations under the banner of the ACCESS Consortium. ACCESS is an acronym based on the first letters of the five countries names.
A few days earlier, on February 22, the US Food and Drug Administration (FDA) released a similar set of recommendations. They allow Emergency Use Authorizations (EUAs) for investigational vaccines for new variants,
letting them be used on the general public
Research and Markets: Europe Organoids Market Forecast to 2027: Increasing Focus on Drug Discovery Activities & Combining Organoid with Organ-On-A-Chip - ResearchAndMarkets.com
ResearchAndMarkets.com s offering.
Internal Organoids segment is expected to drive the growth of the Europe Organoids Market by Technology.
Europe Organoids Market was valued at US$ 247.85 million in 2019 and is projected to reach US$ 1,260.08 million by 2027; it is expected to grow at a CAGR of 22.5% during 2020-2027.
The report highlights the trends prevailing in the Europe organoids market and the factors driving the market along with those that act as deterrents to its growth.
Based on type, the organoids market is segmented stomach, intestine, liver, pancreas, lung, brain, kidney, and others. In 2019, the stomach segment accounted for the largest share of the Europe organoids market. The growth of the segment attributes to growth of internal Organoids segment is attributed to the rising stomach d
Made-in-Singapore GermKiller GK Surface™ Disinfectant exhibits efficacy in breaking chain of Covid-19 infections
News Provided By
Share This Article
GermKiller GK Surface Effective against SARS-CoV-2 (COVID-19)
Testing based on US EPA product performance test guidelines for virucides confirms that GK Surface™ inactivates >99.9% of the SARS-CoV-2 virus under 1 minute SINGAPORE, January 26, 2021 /EINPresswire.com/ Vance Chemicals Pte. Ltd. (“Vance Chemicals”) announces today that its flagship disinfectant product, GK-GermKiller
®GK Surface™ (“GK Surface™”), has been scientifically proven to be more than 99.9% effective in inactivating the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within one minute. SARS-Cov-2 is the virus that causes the respiratory illness responsible for the COVID-19 pandemic [1].